Ken Inoki, M.D., Ph.D.
(He/him/his)
Biography
In response to growth factors and nutrients, target of rapamycin (TOR) plays essential roles in a wide array of cellular processes including protein synthesis, lipid and nucleotide biogenesis, gene transcription, apoptosis, and autophagy. Dysregulation of the mechanistic/mammalian TOR (mTOR) signaling pathway is involved in the development of various human diseases including cancer and metabolic disorders.
Using biochemical and genetic approaches, we investigate the function and regulation of the mTOR signaling pathway and the role of mTOR signaling in the development of human health problems.
Research
Our research interests include the clarification of biochemical mechanisms underlying nutrient- or growth factor-induced mTOR complex 1 activation. Through non-biased proteomics approaches, we explore novel regulatory proteins that act as amino acid or lipid sensors for regulating cellular mTORC1 activity.
By using mouse models, we investigate the pathophysiological roles of these proteins in the development of cancer and metabolic disorders.
Condition Focus
Center, Institute, and Program Affiliations
Career Track
Language Proficiency
- Japanese - Read/Write/Speak